Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Dr Reddy’s delays semaglutide supply due to active ingredient issue

Summary by WTVB
July 9 (Reuters) - Dr Reddy's Laboratories said on Thursday that it is delaying commercial supplies of semaglutide due to ​an issue related to the active ‌pharmaceutical ingredient used in the drug, sending its shares down. Semaglutide is the key ingre...

2 Articles

WTVBWTVB
Center

Dr Reddy’s delays semaglutide supply due to active ingredient issue

July 9 (Reuters) - Dr Reddy's Laboratories said on Thursday that it is delaying commercial supplies of semaglutide due to ​an issue related to the active ‌pharmaceutical ingredient used in the drug, sending its shares down. Semaglutide is the key ingre...

Read Full Article
The Hindu Business LineThe Hindu Business Line
Lean Right

Dr Reddy's delays semaglutide supply due to active ingredient issue

The drugmaker said certain batches of semaglutide were found to be out ​of specification and ‌that it is investigating the root cause and taking measures to ensure product quality

·Chennai, India
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center, 50% of the sources lean Right
50% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Hindu Business Line broke the news in Chennai, India on Thursday, July 9, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

GLP-1 icon

GLP-1

Hyderabad, India icon

Hyderabad, India

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal